Puberty is the normal developmental stage when reproductive capacity is attained Disturbances of pubertal timing affect over 4% of the population Deranged pubertal timing has significance for public health in view of the association between early or late puberty and an adverse cardiovascular, metabolic and cancer risk profile 1-3
Background -Puberty
Condition of healthy individuals with pubertal onset delayed by more than 2 standard deviations Repeatedly been shown to cluster in families, often with AD pattern 6 , but pathophysiology and genetic regulation remain unclear Very limited number of rare, high impact genetic variants identified in families with both hypogonadotropic hypogonadism (HH) and DP 7 Our cohort was collected from patients seen under specialist Clinical details of this family revealed them to have typical features of self-limited DP. The proband case was first investigated for growth delay at 12.8yrs, at which time his bone age was 11yrs. His sister's age at menarche was 15yr; both had normal birth weight and birth length. Their father and paternal uncle and aunt all had delayed puberty with delayed linear growth.
4 genes which passed rare variant burden testing included one gene known to cause HH: HS6ST1 1 pathogenic variant in 6 members of one family was validated Figure 5 . Expression pattern of Hs6st1 mRNA in mouse and human developing brain Hs6st1 expression was observed from e11.5, and from e12 until e17.5 strong expression was seen in the vomeronasal organ (VNO) and olfactory epithelium (OE), as well as in the nasal mesenchyme (NM) (panel A, at e14.5).
The timing of pubertal onset has high heritability; 60-80% of variation is genetically determined 4 -however, GWAS of age at menarche only account for 3.6 -6.1% of variability 5 We hypothesise that low-frequency, high or intermediate-impact variants will be enriched in a delayed puberty (DP) population at the extreme of normal pubertal timing (Figure 1 ).
HS6ST1 mutations have been previously identified in up to 2% of patients with IHH 7 HS6ST1 codes for an enzyme which modifies extracellular matrix components critical for normal neural branching Known to be required for the function of FGFR1 and KAL1 in vivo 
Self-Limited DP
Mouse embryo studies show strong expression of HS6ST1 mRNA (in purple) from e11.5, mainly within the vomeronasal organ and olfactory epithelium (Fig. 5) .
Figure 2. Our strategy for identification of new variants
Began by whole exome sequencing in our 7 most extensive families. Variants returned were filtered by a classic bioinformatics pipeline looking for rare, deleterious variants that segregate with the delayed puberty trait in each family. Then looked for genes with variants in more than one family, with possible biological relevance to the disease, including those 20-30 genes known to be determinants in HH. Followed by targeted resequencing in top 28 candidate genes in a further 42 families from our cohort. After normalising the enzymatic activity to the densitometric measure of the bands, we showed reduced activity of the mutant protein compared to WT. Sulphotransferase activity was within the range of previously published 7 HS6ST1 mutations causing HH, towards the less deleterious end of the spectrum.
In human 9pcw brains, HS6ST1 expression pattern was similar to that observed in mouse, with GnRH neurons interspersed in an HS6ST1-positive NM (C&D, frontal sections). GnRH neurons are shown in brown (panels C&D). Sense probes resulted in no specific signal (mouse probe shown in panel B, human probe not shown). NSnasal septum.
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